MEDICINE & HEALTH

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories Emerging as Major Player in Biosimilars Market

Dr. Reddy's Laboratories (NYSE: RDY) (NSE: DRREDDY), a global pharmaceutical company, has been making significant advancements in the field of biosimilars, positioning itself as a major player in the field. With the rapidly growing global biosimilar market, which reached $16.8 billion in 2022 and is projected to reach $77.1 billion by 2028, there is a pressing need for high-quality and affordable biosimilar products.
Photo by Towfiqu barbhuiya on Unsplash

The Path to Healing After a Motor Vehicle Accident

In the aftermath of a car crash, it is imperative to focus on the healing process - and this doesn't only involve your physical injuries but also the mental suffering you experience as a consequence of what you've been through.

Recommended Stories

Real Time Analytics